In the U.S., Keytruda, also known as pembrolizumab, is approved for certain cases of endometrial carcinoma as a late-line option.

Endometrial cancer is one of the most common gynaecological cancers in high-income countries and, for many years, has been ...

It also brings the UK as a whole into line with Scotland, which backed the combination for advanced or recurrent endometrial cancer in October 2022. When diagnosed and treated early, endometrial ...

Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli ...

GSK has claimed US approval for Jemperli alongside chemotherapy for previously untreated, primary advanced or recurrent endometrial cancer, becoming the first immunotherapy option for first-line ...

The Mayo Clinic and Exact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with abnormal vaginal bleeding. It analyzes vaginal fluid collected on tampons for ...

The safety and efficacy of dostarlimab plus chemotherapy in patients with advanced endometrial cancer were confirmed by ...

highlighting promising response rates for biomarker-positive patients with endometrial cancer and raising the possibility of an accelerated pathway in the second-line setting.